SIM
TLOG

Spark Investment Management’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Spark Investment Management’s Portfolio TLOG Stock Details TLOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-11,100
Closed -$25K – 823
2015
Q2 		$25K Buy
+11,100
New +$34.2K ﹤0.01% 649
2015
Q1 		– Sell
-15,500
Closed -$74K – 817
2014
Q4 		$74K Buy
+15,500
New +$69.3K 0.01% 613

Other funds holding TLOG

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Spark Investment Management's TLOG Position: Q3 2015 in Review

Spark Investment Management sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q3 2015, closing a stake of 11,100 shares — an estimated $25K sold.

Spark Investment Management first reported a position in TLOG in Q4 2014 and held it in 2 quarters. The position peaked at $74K in Q4 2014. 29 funds tracked by Wall St. Rank hold TLOG as of Q3 2015.

  • Spark Investment Management reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q3 2015 after selling out during the quarter.
  • Spark Investment Management sold 11,100 TetraLogic Pharmaceuticals Corporation shares in Q3 2015, an estimated $25K.
  • Spark Investment Management first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2014 and held it in 2 quarters.
  • Spark Investment Management's TetraLogic Pharmaceuticals Corporation position peaked at $74K in Q4 2014.
  • 29 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q3 2015.

Based on Spark Investment Management's 13F filing for Q3 2015, filed 12 Nov 2015.